Report error Found 558 Enz. Inhib. hit(s) with all data for entry = 12729
Affinity DataIC50: 1.14E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 1.16E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 1.16E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 1.18E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 1.21E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 1.22E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 1.30E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 1.31E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 1.43E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 1.56E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 1.86E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 1.95E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 2.03E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 2.05E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 2.07E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 2.23E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 2.24E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 2.27E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 2.43E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 2.50E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 2.50E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 2.50E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 2.50E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 2.50E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 2.50E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 2.50E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 2.50E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 2.50E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 2.50E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 2.50E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 2.50E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 2.50E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 2.55E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 3.37E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 3.50E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 3.62E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 3.81E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 5.21E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 5.80E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 6.13E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
Affinity DataIC50: 6.70E+3nMAssay Description:The recombinant SARS-CoV-2 Mpro (with a final concentration of 750 nM) was mixed with a series of dilutions for each compound in 25 μL assay buffer (...More data for this Ligand-Target Pair
